[Featured Stock] Selvas Healthcare Rises on Optimism for Medical AI Boom

Selvas Healthcare is showing strong performance in the early trading session. This is interpreted as a positive influence on the stock price following the visit of the head of OpenAI, the developer of ChatGPT, to Korea, where he expressed intentions to develop a medical ChatGPT.

As of 9:35 AM on the 6th, Selvas Healthcare's stock price is trading at 5,560 KRW, up 11.42% (570 KRW) from the previous day.

The rise in stock price appears to be linked to remarks made by Sam Altman, CEO of OpenAI, who recently visited Korea. At the 'Builder Lab' developer workshop held in Seoul on the 4th, CEO Altman stated, "The medical group is in the process of ensuring HIPAA (Health Insurance Portability and Accountability Act) compliance for enterprise products so that all OpenAI products can be used," raising expectations for the medical AI market.

Lee Jun-seok, a researcher at Hanyang Securities, commented, "Medical AI companies experienced a correction due to a lack of revenue visibility after reaching their stock price peak in 2023," adding, "Medical AI technology is a field leading medical innovation by analyzing medical data, diagnosing diseases, and supporting treatment plans, and continuous growth is expected."

This content was produced with the assistance of AI translation services.